Atlas Trials

Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients

Clinical trial NCT02143050 · WITHDRAWN

Trial details

NCT number
NCT02143050
Sponsor
University of Louisville
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Melanoma
Start date
2014-09-01
Primary completion
2017-11-17
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.